Production (Stage)
Utah Medical Products, Inc.
UTMD
$53.76
$0.100.19%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.03% | -8.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.03% | -8.47% | |||
| Cost of Revenue | 8.79% | -8.76% | |||
| Gross Profit | 4.04% | -8.26% | |||
| SG&A Expenses | -0.93% | 3.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.98% | -5.73% | |||
| Operating Income | 6.12% | -13.02% | |||
| Income Before Tax | 6.75% | -13.52% | |||
| Income Tax Expenses | 14.75% | 15.58% | |||
| Earnings from Continuing Operations | 4.79% | -18.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.79% | -18.55% | |||
| EBIT | 6.12% | -13.02% | |||
| EBITDA | 4.82% | -11.15% | |||
| EPS Basic | 7.25% | -16.39% | |||
| Normalized Basic EPS | 8.08% | -11.67% | |||
| EPS Diluted | 7.35% | -16.10% | |||
| Normalized Diluted EPS | 8.07% | -11.67% | |||
| Average Basic Shares Outstanding | -2.30% | -2.58% | |||
| Average Diluted Shares Outstanding | -2.30% | -2.58% | |||
| Dividend Per Share | 0.00% | 1.67% | |||
| Payout Ratio | -0.07% | 0.21% | |||